Breast cancer, a heterogeneous disease composed of distinct biological subtypes, can be divided into four simple subtypes based on ER, PR and HER2 status: hormone receptor (HR)+/HER2−, HR+/HER2+, HR−/HER+, and HR−/HER2− [12–14]. This evidence concerns the gene ERBB2 and breast cancer.